368075.fig.003a
(a)
368075.fig.003b
(b)
Figure 3: U87MG tumor uptake for 111In-DOTA-AgRP-7C and 111In-DOTA-AgRP-6E at 0.5, 2, and 24 h p.i. (a). Tumor (T)-to-normal organ ratios for 111In-DOTA-AgRP-7C with or without c(RGDyK) blocking peptide at 2 h after the injection of the probe (b).